PHARMACOLOGY REVIEW FOR NURS
5334 FINAL EXAM LATEST EDITION
DETAILED SOLUTIONS 2024
Drugs \combined \with \Hydrocodone \- \ANS-Aspirin, \Acetaminophen, \Ibuprofen
Benzodiazepines \and \CNS \depressants \with \acetaminophen-hydrocodone \- \ANS-False, \this
\could \lead \to \respiratory \depression
Buprenorphine \for \maintenance \after \opioid \abuse \- \ANS-Partial \opioid \agonist \that \activated
\opioid \receptors \but \produces \less \degree \of \euphoria \and \physical \dependence \compared
\to \a \full \agonist
Naltrexone \for \maintenance \after \opioid \abuse \- \ANS-Naltrexone \is \a \opioid \antagonist \that
\blocks \the \euphoric \and \sedative \effects \of \opioids.
Side \effects \of \Hydrocodone \- \ANS-Constipation, \Respiratory \depression, \Addiction
MOA \of \Sumatriptan \- \ANS-Selective \agonist \for \serotonin \5HT \receptors \on \intracranial
\blood \vessels \and \sensory \nerves \of \the \trigeminal \system, \causes \VASOCONSTRICTION \and
\reduces \neurogenic \inflammation
Feverfew \use \- \ANS-Migraine \Prophylaxis
Drugs \that \cannot \be \combined \with \Feverfew \- \ANS-Antiplatlets, \Anticoagulants, \Increased
\risk \of \bleeding \in \patients \taking \antiplatelets \(Aspirin) \and \anticoagulants \(Warfarin)
Folic \acid \for \Folic \Acid \Deficiency \- \ANS-Give \1-2mg/day \PO \for \a \deficiency
Folic \acid \for \women \of \childbearing \age \- \ANS-400-800 \mcg \daily
,Folic \acid \for \pregnant \women \- \ANS-400-600 \mcg/day
Tacrolimus \and \Pimecrolimus \cream \use \- \ANS-Atopic \Dermatitis \(Eczema)
Safe \drug \classes \in \later \pregnancy \- \ANS-Beta \blockers
Safe \medications \for \pregnant \women \- \ANS-Methyldopa \and \Labetalol \are \the \traditional
\agents \of \choice \for \pregnant \women
Methyldopa \and \Labetalol \use \in \pregnancy \- \ANS-These \drugs \have \limited \effects \on
\uteroplacental \and \fetal \hemodynamics \and \do \not \adversely \affect \the \fetus \or \neonate
Anticholinergics \for \drooling \in \Parkinson's \- \ANS-True
Medication \for \COPD \with \eosinophils \312 \- \ANS-Salmeterol \+ \aclidinium \+ \Budesonide
COPD \Group \A \- \ANS-Bronchodilator
COPD \Group \B \- \ANS-LABA \+ \LAMA
COPD \Group \E \- \ANS-LABA \+ \LAMA
Body \fat \percentage \effect \on \lipid \soluble \drugs \- \ANS-The \higher \the \body \fat \percentage
\the \more \the \plasma \levels \of \lipid \soluble \drugs \will \be \reduced
Lean \mass \decrease \effect \on \water \soluble \drugs \- \ANS-Increased
Malnourished \elderly \patients \and \protein \binding \drugs \- \ANS-Increase
, Proquad \Vaccine \education \- \ANS-Deposited \getting \the \vaccine \there \is \still \a \chance \your
\child \could \get \breakthrough \chickenpox
Starting \dosage \of \thyroid \medication \for \51-year-old \- \ANS-50 \mcg
Starting \dosage \of \thyroid \medication \for \68-year-old \- \ANS-25 \mcg
Dosage \range \for \thyroid \medication \with \CAD \- \ANS-12-25 \mcg
Attenuated \vaccine \definition \- \ANS-Live \Virus, \but \weakened
Immunocompromised \patients \and \Attenuated \Vaccines \- \ANS-False, \live \vaccines \can \be
\dangerous \in \recipients \who \are \immunocompromised \because \these \people \are \unable \to
\mount \an \effective \immune \response, \even \against \a \virulent \organism
TDap \vaccine \administration \window \for \pregnant \women \- \ANS-29 \- \36 \weeks
Gardasil \protection \in \females \- \ANS-HPV \6, \11, \16, \18, \31, \33, \45, \52, \58, \Cervical \Cancer,
\Vaginal \Cancer, \Vulvar \Cancer, \Genital \Warts
Gardasil \protection \in \males \- \ANS-HPV \6, \11, \16, \18, \31, \33, \45, \52, \58, \Genital \Warts
MOA \of \Haloperidol \- \ANS-Blocking \the \dopamine \D2 \receptors \in \the \brain, \inhibiting \the
\dopamine \receptors \help \reduce \the \symptoms \of \psychosis \such \as \hallucinations
Adverse \effects \of \Haloperidol \- \ANS-Extrapyramidal \Side \Effects
MOA \of \Chlorpromazine \- \ANS-Blocking \dopamine \D2 \receptors \in \the \brain
Extrapyramidal \symptoms \- \ANS-Dystonia, \Tardive \dyskinesia, \Akathisia, \Pseudoparkinsonism
5334 FINAL EXAM LATEST EDITION
DETAILED SOLUTIONS 2024
Drugs \combined \with \Hydrocodone \- \ANS-Aspirin, \Acetaminophen, \Ibuprofen
Benzodiazepines \and \CNS \depressants \with \acetaminophen-hydrocodone \- \ANS-False, \this
\could \lead \to \respiratory \depression
Buprenorphine \for \maintenance \after \opioid \abuse \- \ANS-Partial \opioid \agonist \that \activated
\opioid \receptors \but \produces \less \degree \of \euphoria \and \physical \dependence \compared
\to \a \full \agonist
Naltrexone \for \maintenance \after \opioid \abuse \- \ANS-Naltrexone \is \a \opioid \antagonist \that
\blocks \the \euphoric \and \sedative \effects \of \opioids.
Side \effects \of \Hydrocodone \- \ANS-Constipation, \Respiratory \depression, \Addiction
MOA \of \Sumatriptan \- \ANS-Selective \agonist \for \serotonin \5HT \receptors \on \intracranial
\blood \vessels \and \sensory \nerves \of \the \trigeminal \system, \causes \VASOCONSTRICTION \and
\reduces \neurogenic \inflammation
Feverfew \use \- \ANS-Migraine \Prophylaxis
Drugs \that \cannot \be \combined \with \Feverfew \- \ANS-Antiplatlets, \Anticoagulants, \Increased
\risk \of \bleeding \in \patients \taking \antiplatelets \(Aspirin) \and \anticoagulants \(Warfarin)
Folic \acid \for \Folic \Acid \Deficiency \- \ANS-Give \1-2mg/day \PO \for \a \deficiency
Folic \acid \for \women \of \childbearing \age \- \ANS-400-800 \mcg \daily
,Folic \acid \for \pregnant \women \- \ANS-400-600 \mcg/day
Tacrolimus \and \Pimecrolimus \cream \use \- \ANS-Atopic \Dermatitis \(Eczema)
Safe \drug \classes \in \later \pregnancy \- \ANS-Beta \blockers
Safe \medications \for \pregnant \women \- \ANS-Methyldopa \and \Labetalol \are \the \traditional
\agents \of \choice \for \pregnant \women
Methyldopa \and \Labetalol \use \in \pregnancy \- \ANS-These \drugs \have \limited \effects \on
\uteroplacental \and \fetal \hemodynamics \and \do \not \adversely \affect \the \fetus \or \neonate
Anticholinergics \for \drooling \in \Parkinson's \- \ANS-True
Medication \for \COPD \with \eosinophils \312 \- \ANS-Salmeterol \+ \aclidinium \+ \Budesonide
COPD \Group \A \- \ANS-Bronchodilator
COPD \Group \B \- \ANS-LABA \+ \LAMA
COPD \Group \E \- \ANS-LABA \+ \LAMA
Body \fat \percentage \effect \on \lipid \soluble \drugs \- \ANS-The \higher \the \body \fat \percentage
\the \more \the \plasma \levels \of \lipid \soluble \drugs \will \be \reduced
Lean \mass \decrease \effect \on \water \soluble \drugs \- \ANS-Increased
Malnourished \elderly \patients \and \protein \binding \drugs \- \ANS-Increase
, Proquad \Vaccine \education \- \ANS-Deposited \getting \the \vaccine \there \is \still \a \chance \your
\child \could \get \breakthrough \chickenpox
Starting \dosage \of \thyroid \medication \for \51-year-old \- \ANS-50 \mcg
Starting \dosage \of \thyroid \medication \for \68-year-old \- \ANS-25 \mcg
Dosage \range \for \thyroid \medication \with \CAD \- \ANS-12-25 \mcg
Attenuated \vaccine \definition \- \ANS-Live \Virus, \but \weakened
Immunocompromised \patients \and \Attenuated \Vaccines \- \ANS-False, \live \vaccines \can \be
\dangerous \in \recipients \who \are \immunocompromised \because \these \people \are \unable \to
\mount \an \effective \immune \response, \even \against \a \virulent \organism
TDap \vaccine \administration \window \for \pregnant \women \- \ANS-29 \- \36 \weeks
Gardasil \protection \in \females \- \ANS-HPV \6, \11, \16, \18, \31, \33, \45, \52, \58, \Cervical \Cancer,
\Vaginal \Cancer, \Vulvar \Cancer, \Genital \Warts
Gardasil \protection \in \males \- \ANS-HPV \6, \11, \16, \18, \31, \33, \45, \52, \58, \Genital \Warts
MOA \of \Haloperidol \- \ANS-Blocking \the \dopamine \D2 \receptors \in \the \brain, \inhibiting \the
\dopamine \receptors \help \reduce \the \symptoms \of \psychosis \such \as \hallucinations
Adverse \effects \of \Haloperidol \- \ANS-Extrapyramidal \Side \Effects
MOA \of \Chlorpromazine \- \ANS-Blocking \dopamine \D2 \receptors \in \the \brain
Extrapyramidal \symptoms \- \ANS-Dystonia, \Tardive \dyskinesia, \Akathisia, \Pseudoparkinsonism
